TY - BOOK ID - 14306695 TI - T-cell lymphomas PY - 2013 SN - 1627031693 1627031707 1283849216 PB - New York : Humana Press, DB - UniCat KW - Lymphomas. KW - Neoplasms. KW - T cells. KW - Lymphomas KW - Lymphoma, Non-Hodgkin KW - Lymphoma KW - Lymphoproliferative Disorders KW - Neoplasms by Histologic Type KW - Neoplasms KW - Lymphatic Diseases KW - Immunoproliferative Disorders KW - Diseases KW - Hemic and Lymphatic Diseases KW - Immune System Diseases KW - Lymphoma, T-Cell KW - Medicine KW - Health & Biological Sciences KW - Oncology KW - Pathology KW - T lymphocytes KW - Thymus-dependent cells KW - Thymus-dependent lymphocytes KW - Thymus-derived cells KW - Germinoblastomas KW - Immunoblastomas KW - Non-Hodgkin's lymphoma KW - Reticulolymphosarcomas KW - Sarcoma, Germinoblastic KW - Sarcoma, Immunoblastic KW - Medicine. KW - Angiology. KW - Hematology. KW - Oncology. KW - Medicine & Public Health. KW - Lymphocytes KW - Lymphoproliferative disorders KW - Reticulo-endothelial system KW - Tumors KW - Oncology . KW - Angiography. KW - Blood-vessels KW - Diagnosis, Radioscopic KW - Radiography, Medical KW - Haematology KW - Internal medicine KW - Blood KW - Radiography UR - https://www.unicat.be/uniCat?func=search&query=sysid:14306695 AB - The mature T and NK cell lymphomas are rare, comprising approximately 10% of all malignant lymphomas. The incidence of T-cell lymphoma is variable around the world, with a higher incidence compared to B-cell lymphomas in the Asian basin. While the overall incidence of B-cell lymphomas has begun to decline in the United States, the incidence of T-cell lymphomas continues to rise. Over the last decade, a number of novel agents have been developed which target T-cell lymphomas and studies have identified novel genes and pathways associated with lymphomagenesis in T-cells. This comprehensive volume examines the clinical and biological aspects of the T-cell lymphoproliferative disorders in adults and children. The book includes an overview of both the cutaneous and the systemic T-cell malignancies and addresses the classification of T-cell lymphomas, the clinical features of each subtype, and the relevant molecular and genetic studies. Clinical outcomes and treatment strategies are discussed with an emphasis on the development of novel biological and targeted therapies. An outstanding resource for hematologists and oncologists, this book gathers insights from experts in the field and provides the most up-to-date information on all of the T-cell lymphoma subgroups and current and emerging therapies. ER -